556 related articles for article (PubMed ID: 17006979)
41. Surgical management of Zollinger-Ellison syndrome: Classical considerations and current controversies.
Shao QQ; Zhao BB; Dong LB; Cao HT; Wang WB
World J Gastroenterol; 2019 Aug; 25(32):4673-4681. PubMed ID: 31528093
[TBL] [Abstract][Full Text] [Related]
42. Prospective study of the use of intraarterial secretin injection and portal venous sampling to localize duodenal gastrinomas.
Thom AK; Norton JA; Doppman JL; Miller DL; Chang R; Jensen RT
Surgery; 1992 Dec; 112(6):1002-8; discussion 1008-9. PubMed ID: 1455303
[TBL] [Abstract][Full Text] [Related]
43. Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features.
Berna MJ; Hoffmann KM; Long SH; Serrano J; Gibril F; Jensen RT
Medicine (Baltimore); 2006 Nov; 85(6):331-364. PubMed ID: 17108779
[TBL] [Abstract][Full Text] [Related]
44. Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome).
Creutzfeldt W; Arnold R; Creutzfeldt C; Track NS
Hum Pathol; 1975 Jan; 6(1):47-76. PubMed ID: 45919
[TBL] [Abstract][Full Text] [Related]
45. Gastrin Induces Nuclear Export and Proteasome Degradation of Menin in Enteric Glial Cells.
Sundaresan S; Meininger CA; Kang AJ; Photenhauer AL; Hayes MM; Sahoo N; Grembecka J; Cierpicki T; Ding L; Giordano TJ; Else T; Madrigal DJ; Low MJ; Campbell F; Baker AM; Xu H; Wright NA; Merchant JL
Gastroenterology; 2017 Dec; 153(6):1555-1567.e15. PubMed ID: 28859856
[TBL] [Abstract][Full Text] [Related]
46. Management of patients with Zollinger-Ellison syndrome.
Meko JB; Norton JA
Annu Rev Med; 1995; 46():395-411. PubMed ID: 7598474
[TBL] [Abstract][Full Text] [Related]
47. The gastrinoma/Zollinger-Ellison syndrome: statistical evaluation of a Japanese series of 359 cases.
Soga J; Yakuwa Y
J Hepatobiliary Pancreat Surg; 1998; 5(1):77-85. PubMed ID: 9683758
[TBL] [Abstract][Full Text] [Related]
48. Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1.
MacFarlane MP; Fraker DL; Alexander HR; Norton JA; Lubensky I; Jensen RT
Surgery; 1995 Dec; 118(6):973-9; discussion 979-80. PubMed ID: 7491542
[TBL] [Abstract][Full Text] [Related]
49. Duodenal gastrinoma: the solution to the pancreatic paradox.
Modlin IM; Lawton GP
J Clin Gastroenterol; 1994 Oct; 19(3):184-8. PubMed ID: 7806825
[TBL] [Abstract][Full Text] [Related]
50. Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases, or survival in patients with Zollinger-Ellison syndrome?
Norton JA; Alexander HR; Fraker DL; Venzon DJ; Gibril F; Jensen RT
Ann Surg; 2004 May; 239(5):617-25; discussion 626. PubMed ID: 15082965
[TBL] [Abstract][Full Text] [Related]
51. Metastatic Patterns of Duodenopancreatic Neuroendocrine Tumors in Patients With Multiple Endocrine Neoplasia Type 1.
Hackeng WM; van Beek DJ; Kok ASM; van Emst M; Morsink FHM; van Treijen MJC; Borel Rinkes IHM; Dreijerink KMA; Offerhaus GJA; Valk GD; Vriens MR; Brosens LAA
Am J Surg Pathol; 2022 Feb; 46(2):159-168. PubMed ID: 34560682
[TBL] [Abstract][Full Text] [Related]
52. A Parathyroid-Gut Axis: Hypercalcemia and the Pathogenesis of Gastrinoma in Multiple Endocrine Neoplasia 1.
Hackeng WM; Dreijerink KMA; Offerhaus GJA; Brosens LAA
Mol Cancer Res; 2021 Jun; 19(6):946-949. PubMed ID: 33771883
[TBL] [Abstract][Full Text] [Related]
53. Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both.
Thompson NW
J Intern Med; 1998 Jun; 243(6):495-500. PubMed ID: 9681848
[TBL] [Abstract][Full Text] [Related]
54. Gastrinoma: advances in localization and treatment.
Norton JA
Surg Oncol Clin N Am; 1998 Oct; 7(4):845-61. PubMed ID: 9735137
[TBL] [Abstract][Full Text] [Related]
55. [Surgical therapy of gastrinoma with associated Zollinger-Ellison syndrome].
Schröder W; Hölscher AH; Beckurts KT; Schusdziarra V; Höfler H; Siewert JR
Z Gastroenterol; 1996 Aug; 34(8):465-72. PubMed ID: 8967120
[TBL] [Abstract][Full Text] [Related]
56. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.
Alexander HR; Fraker DL; Norton JA; Bartlett DL; Tio L; Benjamin SB; Doppman JL; Goebel SU; Serrano J; Gibril F; Jensen RT
Ann Surg; 1998 Aug; 228(2):228-38. PubMed ID: 9712569
[TBL] [Abstract][Full Text] [Related]
57. Multiple endocrine neoplasm, type 1. Gastrinomas, pancreatic neoplasms, microcarcinoids, the Zollinger-Ellison syndrome, lymph nodes, and hepatic metastases.
Shepherd JJ; Challis DR; Davies PF; McArdle JP; Teh BT; Wilkinson S
Arch Surg; 1993 Oct; 128(10):1133-42. PubMed ID: 8105768
[TBL] [Abstract][Full Text] [Related]
58. Spatial profiling reveals tissue-specific neuro-immune interactions in gastroenteropancreatic neuroendocrine tumors.
Duan S; Sawyer TW; Witten BL; Song H; Else T; Merchant JL
J Pathol; 2024 Mar; 262(3):362-376. PubMed ID: 38229586
[TBL] [Abstract][Full Text] [Related]
59. Contemporary surgical management of the Zollinger-Ellison syndrome in multiple endocrine neoplasia type 1.
Albers MB; Manoharan J; Bartsch DK
Best Pract Res Clin Endocrinol Metab; 2019 Oct; 33(5):101318. PubMed ID: 31521501
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
